sdbn.org

Drug Development, News, Syndication, Xconomy »

San Diego’s MediciNova Nears Turning Point with Lead Drug for Asthma
Posted by sandiegobiotech May 8th, 2012 .
No Comments

[Corrected 5/7/12, 5:10 pm. See below.] When Yuichi Iwaki started MediciNova in 2000, he says many mid-size pharmaceutical companies in Japan had concluded it was just too difficult to conduct their...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

San Diego’s Celladon Extends Round to $53M, Opens European Office
Posted by sandiegobiotech May 8th, 2012 .
No Comments

San Diego-based Celladon, which raised $43 million in February to advance development of a gene therapy treatment for heart disease, has extended the round with an additional $10 million, according...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

First Comes The $1,000 genome, Then Comes The $10,000 Analysis
Posted by sandiegobiotech May 8th, 2012 .
No Comments

While everyone in the in the world of sequencing has heard this cynical joke, as an industry, the joke is about to be on us. We have focused our time, energy and investment on the ability to sequence...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

Vertex Shares Boom on Cystic Fibrosis Results
Posted by sandiegobiotech May 7th, 2012 .
No Comments

[Updated: 9:40 am ET] Vertex Pharmaceuticals wowed the cystic fibrosis community earlier this year with its new drug that improves lung function for patients with a rare form of the inherited...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

Antibiotic R&D is in Trouble: Here’s One Way to Fix It
Posted by sandiegobiotech May 7th, 2012 .
No Comments

Bacteria have been on Earth for more than a billion years, evolving in crafty ways to stay alive amid all kinds of threats. Only about 70 years ago, antibiotics came along and became one of the great...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

SD Life Sciences Roundup: Gen-Probe, Zogenix, & the Innovation Economy
Posted by sandiegobiotech May 3rd, 2012 .
No Comments

Here’s our wrap-up of life sciences news over the past week, along with some life sciences data from the latest Connect Innovation Report. —Bedford, MA-based Hologic (NASDAQ: HOLX) agreed to pay $3.7...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

Virtual Biotech Companies: Built on Solid Bedrock or Unstable Landfill?
Posted by sandiegobiotech May 3rd, 2012 .
No Comments

A recent meeting focused on “Reinventing Biotech’s Business Model” provided an interesting window into the spectrum of approaches being used to create new biotech companies. Unfortunately, it did...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

5 Things to Do Before the New Patent Law Takes Full Effect
Posted by sandiegobiotech May 2nd, 2012 .
No Comments

On September 16, 2011, President Obama signed into law the America Invents Act, the most important modification to U.S. patent law in 60 years—and some even argue, since 1836. Some changes went into...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

Innovation Report Shows San Diego Added 695 Tech Jobs at End of 2011
Posted by sandiegobiotech May 1st, 2012 .
No Comments

San Diego’s innovation economy added 75 new technology companies and 695 jobs during the last three months of 2011, according to the Connect Innovation Report for the fourth quarter of 2011. New jobs...

[[Click headline to continue reading.]] More...

Diagnostics, News, Syndication, Xconomy »

Hologic Buys Gen-Probe for $3.7B, Making Molecular Diagnostics Push
Posted by sandiegobiotech April 30th, 2012 .
No Comments

Hologic has made big-money acquisitions before, and today it’s making another sizable one. The Bedford, MA-based maker of women’s health products (NASDAQ: HOLX) said today it has agreed to purchase...

[[Click headline to continue reading.]] More...